Structure Therapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Structure Therapeutics Inc. has issued its 2026 proxy statement detailing proposals for the upcoming annual general meeting of shareholders on June 17, 2026.
NASDAQ
Structure Therapeutics will hold its 2025 Annual General Meeting virtually on June 23, 2025, to vote on director elections, auditor ratification, executive compensation, and the frequency of say-on-pay votes.
NASDAQ
Structure Therapeutics will hold its 2024 Annual General Meeting of Shareholders virtually on June 25, 2024, to vote on the election of a director and ratification of the company's independent auditor.